KRAS and cancer: Oncogenic KRas has also been found to cause defects in terminal differentiation of stem or progenitor cells in mouse colon [26] and zebrafish pancreatic [10] cancer models, so it is possible that GFAP expression was lost early during oncogenic KRAS-driven brain tumorigenesis.